MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jvh.13796

Медицинская библиотека · Journal of viral hepatitis · 2023

Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia study.

Leow Yong-Wen, Chan Wah-Kheong, Goh George Boon-Bee, Wong Vincent Wai-Sun, Fan Jian Gao, Kim Young Seok, Kim Seung Up, Nakajima Atsushi, Seto Wai-Kay, Lee I-Cheng, Huang Yi-Hsiang, Kim Yoon Jun, Young Jang Jae, Chow Wan Cheng

Многоцентровое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

We aimed to compare the severity of liver disease, metabolic profile and cardiovascular disease (CVD) risk of chronic hepatitis B (CHB) patients with and without hepatic steatosis and patients with non-alcoholic fatty liver disease (NAFLD). Patients with NAFLD and CHB were prospectively enrolled from 10 Asian centres. Fibroscan was performed for all patients and hepatic steatosis was defined based on controlled attenuation parameter >248 dB/m. CVD risk was assessed using the Framingham risk score. The data for 1080 patients were analysed (67% NAFLD, 33% CHB). A high proportion (59%) of CHB patients had hepatic steatosis. There was a significant stepwise increase in alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, controlled attenuation parameter and liver stiffness measurement, from CHB patients without hepatic steatosis to CHB patients with hepatic steatosis to NAFLD patients (p < 0.001 for all comparisons). There was a significant stepwise increase in the proportion of patients with metabolic syndrome and in CVD risk, with very high or extreme CVD risk seen in 20%, 48% and 61%, across the groups (p < 0.001 between CHB patients with and without hepatic steatosis and p < 0.05 between CHB patients with hepatic steatosis and NAFLD patients). In conclusion, there was a high proportion of CHB patients with hepatic steatosis, which should be diagnosed, as they may have more severe liver disease, so that this and their metabolic risk factors can be assessed and managed accordingly for a better long-term outcome.

Для цитирования: Leow Yong-Wen, Chan Wah-Kheong, Goh George Boon-Bee, Wong Vincent Wai-Sun, Fan Jian Gao, Kim Young Seok, Kim Seung Up, Nakajima Atsushi, Seto Wai-Kay, Lee I-Cheng, Huang Yi-Hsiang, Kim Yoon Jun, Young Jang Jae, Chow Wan Cheng. Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia study.. Journal of viral hepatitis. 2023. DOI: 10.1111/jvh.13796.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.